| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V102818 | CSLP37 | 2244984-64-1 | CSLP37 is a selective RIPK2 inhibitor with IC50 of 16.3 nM. |
|
V2773 | GSK' 872 (GSK2399872A) | 1346546-69-7 | GSK872 (also known asGSK2399872A, GSK872, orGSK-872) is a novel, potent and selective RIPK3 (receptor interacting protein kinase-3) inhibitor. |
|
V41990 | GSK-872 hydrochloride | 2703752-81-0 | GSK-872 hydrochloride (GSK872; GSK2399872A; GSK872; GSK-872) is a novel, potent and selective RIPK3 (receptor interacting protein kinase-3) inhibitor with anticancer and anti-inflammatory effects. |
|
V2776 | GSK2982772 | 1622848-92-3 | GSK2982772 (GSK-2982772; GSK772) is a potent, selective, oral and ATP competitive inhibitor of RIP1 (receptor Interacting Protein 1) with the potentialfor the treatment of inflammatory diseases. |
|
V2611 | GSK583 | 1346547-00-9 | GSK583 is a highly potent and selective RIP2 kinaseinhibitor with an IC50 value of 5 nM. |
|
V143384 | PROTAC RIPK1 Degrader-1 | PROTAC RIPK1 Degrader-1 is a selective RIPK1 PROTAC degrader. | |
|
V88522 | RIP1 kinase inhibitor 9 | RIP1 kinase inhibitor 9 (compound SY-1) is a selective RIP kinase inhibitor. | |
|
V144154 | RIP1-IN-1 | RIP1-IN-1 is an orally effective RIP1 inhibitor with a strong RIP1 binding affinity (Kd: 110 nM). | |
|
V3403 | RIPA-56 | 1956370-21-0 | RIPA-56 is a novel, highly potent, selective, and metabolically stable inhibitor of receptor-interacting protein 1 (RIP1) with anIC50of 13 nM. |
|
V144155 | RIPK1-IN-29 | RIPK1-IN-29 is a RIPK1 inhibitor with an IC50 value of 6.9 nM. | |
|
V144156 | RIPK1-IN-30 | RIPK1-IN-30 is a potent RIPK1 inhibitor with an IC50 of 2.01 μM. | |
|
V144157 | RIPK1-IN-31 | 2857845-45-3 | RIPK1-IN-31 is a selective RIPK1 (receptor-interacting protein kinase 1) allosteric modulator with an IC50 value of 16 nM. |
|
V144160 | RIPK1-IN-36 | 2924736-22-9 | RIPK1-IN-36 is a RIPK1 inhibitor with an EC50 of <25 nM. |
|
V144161 | RIPK1-IN-40 | RIPK1-IN-40 is a RIPK1 inhibitor and an anti-necrotizing apoptosis agent (EC50 for necrotizing apoptosis is 0.07 μM). | |
|
V144162 | RIPK2/3-IN-2 | 3084103-03-4 | RIPK2/3-IN-2 is a dual inhibitor of RIPK2 and RIPK3, with IC50 values of 12 nM and 18 nM, respectively. |
|
V144164 | RIPK3-IN-5 | RIPK3-IN-5 is a potent RIPK3 inhibitor with an IC50 of 27 nM. | |
|
V144165 | RIPK3-IN-6 | 955879-75-1 | RIPK3-IN-6 is a type I RIPK3 inhibitor with poor selectivity for the RIPK family, especially for RIPK2 activity. |
|
V144166 | RIPK3-IN-7 | 3116772-57-4 | RIPK3-IN-7 is a RIPK3 inhibitor that inhibits the RIPK3-mediated necroptosis pathway. |
|
V145598 | Tat-ASIC1a (1-20) (mouse, rat) | Tat-ASIC1a (1-20) (mouse, rat) is a competitive ASIC1a membrane-penetrating peptide. | |
|
V114383 | ZBP1 Covalent PROTAC-1 | ZBP1 covalent PROTAC-1 is a covalent Z-DNA binding protein 1 (ZBP1 PROTAC) degrader with a DC50 value of 25.69 nM. |